# Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)

> **NCT03783351** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Beijing Anzhen Hospital** · enrollment: 4009 (actual)

## Conditions studied

- Angina, Stable
- Acute Coronary Syndrome
- Drug-Eluting Stents
- Genotype

## Interventions

- **GENETIC:** CYP2C19 genotype testing

## Key facts

- **NCT ID:** NCT03783351
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-05-27
- **Primary completion:** 2026-03
- **Final completion:** 2026-04
- **Target enrollment:** 4009 (ACTUAL)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03783351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03783351, "Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03783351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*